z-logo
Premium
Effects of dietary levan on growth performance, nonspecific immunity, pathogen resistance and body composition of orange‐spotted grouper ( E pinephelus coioides H.)
Author(s) -
Huang MeiYing,
Chang ChinI,
Chang ChihChien,
Tseng LiangWei,
Pan ChorngLiang
Publication year - 2015
Publication title -
aquaculture research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.646
H-Index - 89
eISSN - 1365-2109
pISSN - 1355-557X
DOI - 10.1111/are.12430
Subject(s) - grouper , biology , epinephelus , lysozyme , orange (colour) , zoology , food science , microbiology and biotechnology , veterinary medicine , fishery , biochemistry , fish <actinopterygii> , medicine
This study investigated the effects of levan produced by B acillus licheniformis   FRI MY ‐55 on growth performance, intestinal count of viable bacteria, immune status, pathogen resistance and body composition of orange‐spotted grouper ( E pinephelus coioides ). Orange‐spotted grouper were fed diets supplemented with levan at concentrations of 0 (control), 5.0, 10.0, 25.0 and 50.0 g kg −1 for 12 weeks. The final weight and per cent weight gain were significantly higher in the 25.0 g kg −1 levan‐supplemented group than in the control group ( p  <   0.05). All levan‐supplemented diets significantly decreased the count of total viable aerobic bacteria and Vibrio spp. in the intestines of groupers ( p  <   0.05). Serum total protein levels, globulin levels, lysozyme activity and survival rate of orange‐spotted grouper after challenge with V. harveyi were significantly higher in the 25.0 g kg −1 levan‐supplemented group than in the control group ( p  <   0.05). This study also found that the 10.0, 25.0 and 50.0 g kg −1 levan‐supplemented diets significantly increased the crude protein level in the body composition of orange‐spotted grouper. Overall, the results of this study indicate that dietary levan (25.0 g kg −1 ) could be an effective method for enhancing the growth performance and disease resistance in orange‐spotted grouper.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here